US scientists find heart attack survivors given canakinumab injections have fewer future heart attacks and lower cancer risk

Anti-inflammatory injections could lower the risk of heart attacks and may slow the progression of cancer, a study has found, in what researchers say is the biggest breakthrough since the discovery of statins.

Heart attack survivors given injections of a targeted anti-inflammatory drug called canakinumab had fewer attacks in the future, scientists found. Cancer deaths were also halved in those treated with the drug, which is normally used only for rare inflammatory conditions.

Continue reading…

Facebook Comments

This site uses Akismet to reduce spam. Learn how your comment data is processed.